We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

AnaSpec Introduces First FRET-based Cathepsin B Assay

Read time: Less than a minute
AnaSpec has announced the release of the SensoLyte® 520 Cathepsin B Activity Assay Kit. This homogeneous assay can be used for measuring Cathepsin B activity and for screening Cathepsin B inhibitors. The substrate employs in this kit is a peptide sequence containing the QXL™ 520/HiLyte Fluor™ 488 FRET pair.

In the intact sequence, the fluorescence of HiLyte Fluor™ 488 is quenched by QXL™ 520. Upon recognition and cleavage by Cathepsin B, the peptide is cleaved into two separate fragments, resulting in the release of HiLyte Fluor™ 488 fluorescence. Fluorescence can be continuously monitored at the green emission range of 520 nm (Ex= 488 nm). The long wavelength fluorescence and pH independent properties of HiLyte Fluor™ 488 mean less interference by autofluorescence of cellular components and test compounds, and the ability to measure Cathepsin B activity at its optimal low pH.

SensoLyte® 440 Cathepsin B Assay Kit containing an AMC labeled peptide substrate, with emission in the blue range (Ex/Em=354/442 nm) is also available.
Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.